|
1
|
Wang Y, Zhao S, Bai L, Fan J and Liu E:
Expression systems and species used for transgenic animal
bioreactors. Biomed Res Int. 2013:5804632013.PubMed/NCBI
|
|
2
|
Echelard Y, Williams JL, Destrempes MM,
Koster JA, Overton SA, Pollock DP, Rapiejko KT, Behboodi E,
Masiello NC, Gavin WG, et al: Production of recombinant albumin by
a herd of cloned transgenic cattle. Transgenic Res. 18:361–376.
2009. View Article : Google Scholar
|
|
3
|
Dyck MK, Lacroix D, Pothier F and Sirard
MA: Making recombinant proteins in animals-different systems,
different applications. Trends Biotechnol. 21:394–399. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Khodarovicha YM, Goldman IL, Sadchikova ER
and Georgiev PG: Expression of eukaryotic recombinant proteins and
deriving them from the milk of transgenic animals. ISSN:
00036838Appl Biochem Microbiol. 49:711–722. 2013. View Article : Google Scholar
|
|
5
|
Song S, Ge X and Cheng Y, Lu R, Zhang T,
Yu B, Ji X, Qi Z, Rong Y, Yuan Y and Cheng Y: High-level expression
of a novel recombinant human plasminogen activator (rhPA) in the
milk of transgenic rabbits and its thrombolytic bioactivity in
vitro. Mol Biol Rep. 43:775–783. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Song S, He Z, Mei J, Qi Z, Chen S, Xu S,
Yuan Y and Cheng Y: Affinity purification of recombinant human
plasminogen activator from transgenic rabbit milk using a novel
polyol responsive monoclonal antibody. Trop J Pharm Res.
15:905–911. 2016. View Article : Google Scholar
|
|
7
|
Meunier JM, Wenker E, Lindsell CJ and Shaw
GJ: Individual lytic efficacy of recombinant tissue plasminogen
activator in an in vitro human clot model: Rate of ‘nonresponse’.
Acad Emerg Med. 20:449–455. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bosze Z, Baranyi M and Whitelaw CB:
Producing recombinant human milk proteins in the milk of livestock
species. Adv Exp Med Biol. 606:357–393. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chevreux G, Faid V, Scohyers JM and
Bihoreau N: N-/O-glycosylation analysis of human FVIIa produced in
the milk of transgenic rabbits. Glycobiology. 23:1531–1546. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gil GC, Velander WH and Van Cott KE:
Analysis of the Nglycans of recombinant human factor IX purified
from transgenic pig milk. Glycobiology. 7:526–539. 2008. View Article : Google Scholar
|
|
11
|
Koles K, van Berkel PH, Pieper FR, Nuijens
JH, Mannesse ML, Vliegenthart JF and Kamerling JP: N- and O-glycans
of recombinant human C1 inhibit or expressed in the milk of
transgenic rabbits. Glycobiology. 14:51–64. 2004. View Article : Google Scholar
|
|
12
|
Zhang YL, Wan YJ, Wang ZY, Xu D, Pang XS,
Meng L, Wang LH, Zhong BS and Wang F: Production of dairy goat
embryos, by nuclear transfer, transgenic for human acid
Bglucosidase. Theriogenology. 73:681–690. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gordon K and Groet S: Transgenic animals
secreting desired proteins into milk. King George Holdings
Luxembourg Iia S.A.R.L, 2011. US Patent US7939317. Filed February
20, 1992; issued May 10, 2011.
|
|
14
|
Lian LF, Xu F, Tang ZP, Xue Z, Liang QM,
Hu Q, Zhu WH, Kang HC, Liu XY, Wang FR and Zhu SQ: Intra clot
recombinant tissuetype plasminogen activator reduces perihematomal
edema and mortality in patients with spontaneous intracerebral
hemorrhage. J Huazhong Univ Sci Technolog Med Sci. 34:165–171.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dotan A, Kaiserman I, Kremer I, Ehrlich R
and Bahar I: Intracameral recombinant tissue plasminogen activator
(r-tPA)for refractory toxic anterior segment syndrome. Br J
Ophthalmol. 98:252–255. 2014. View Article : Google Scholar
|
|
16
|
Wardlaw JM, Murray V, Berge E, del Zoppo
G, Sandercock P, Lindley RL and Cohen G: Recombinant tissue
plasminogen activator for acute ischaemic stroke: an updated
systematic review and meta-analysis. Lancet. 379:2364–2372. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fonarow GC, Zhao X, Smith EE, Saver JL,
Reeves MJ, Bhatt DL, Xian Y, Hernandez AF, Peterson ED and Schwamm
LH: Door-to-needle times for tissue plasminogen activator
administration and clinical outcomes in acute ischemic stroke
before and after a quality improvement t initiative. JAMA.
311:1632–1640. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meyer MW, Witt AR, Krishnan LK, Yokota M,
Roszkowski MJ, Rudney JD and Herzberg MC: Therapeutic advantage of
recombinant human plasminogen activator in endocarditis: evidence
from experiments in rabbits. Thromb Haemost. 73:680–682.
1995.PubMed/NCBI
|
|
19
|
Smalling RW, Bode C, Kalbfleisch J, Sen S,
Limbourg P, Forycki F, Habib G, Feldman R, Hohnloser S and Seals A:
More rapid, complete, and stable coronary thrombolysis with bolus
administration of reteplase compared with alteplase infusion in
acute myocardial infarction. Circulation. 91:2725–2732. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Aghaabdollahian S, Rabbani M, Ghaedi K and
Sadeghi HM: Molecular cloning of reteplase and its expression in E.
coli using tac promoter. Adv Biomed Res. 3:1902014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong-Ying S, Si-Guo L, Jian-Quan C, Ai-Min
Z and Guo-Xiang C: Expression of a variant of human tissue-type
plasminogen activator in transgenic mouse milk. J Exp Anim Sci.
43:211–218. 2006. View Article : Google Scholar
|
|
22
|
Lijnen HR and Collen D: Strategies for the
improvement of thrombolytic agents. Thromb Haemost. 66:88–110.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Davami F, Sardari S, Majidzadeh-A K,
Hemayatkar M, Barkhrdari F, Omidi M, Azami M, Adeli A, Davoudi N
and Mahboudi F: Expression of a novel chimeric truncated t-PA in
CHO cells based on in silico experiments. J Biomed Biotechnol.
2010:1081592010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takezawa J, Yamada K, Miyachi M, Morita A,
Aiba N, Sasaki S and Watanabe S; Saku Control Obesity Program
(SCOP) Study Group: Preproghrelin gene polymorphisms in obese
Japanese women. Minor homozygotes are light eaters, do not prefer
protein or fat, and apparently have a poor appetite. Appetite.
63:105–111. 2013. View Article : Google Scholar
|
|
25
|
Knox-Macaulay HH, Rehman JU, Al Zadjali S,
Fawaz NA and Al Kindi S: Idiopathic thrombocytopenic purpura and
hypo-kalaemic dRTA with compensated haemolysis and striking
acanthocytosis in a band 3 (SLC4A1/AE1) A858D homozygote. Ann
Hematol. 92:553–554. 2013. View Article : Google Scholar
|
|
26
|
Xue F, Ma Y, Chen YE, Zhang J, Lin TA,
Chen CH, Lin WW, Roach M, Ju JC, Yang L, Du F and Xu J: Recombinant
rabbit leukemia inhibitory factor and rabbit embryonic fibroblasts
support the derivation and maintenance of rabbit embryonic stemb
cells. Cell Reprogram. 14:364–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fan J and Watanabe T: Transgenic rabbits
as therapeutic protein bioreactors and human disease models.
Pharmacol Ther. 99:261–282. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Goldman IL, Georgieva SG, Gurskiy YG,
Krasnov CA, Deykin CA, Popov AN, Ermolkevich TG, Budzevich AI,
Chernousov AD and Sadchikova ER: Production of human lactoferrin in
animal milk. Biochem Cell Biol. 90:513–519. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pollock DP, Kutzko JP, Birck-Wilson E,
Williams JL, Echelard Y and Meade HM: Transgenic milk as a method
for the production of recombinant antibodies. J Immunol Methods.
231:147–157. 1999. View Article : Google Scholar
|
|
30
|
Zhou Q, Kyazike J, Echelard Y, Meade HM,
Higgins E, Cole ES and Edmunds T: Effect of genetic background on
glycosylation heterogeneity in human antithrombin produced in the
mammary gland of transgenic goats. J Biotechnol. 117:57–72. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Granelli-Piperno A and Reich E: A study of
proteases and protease-inhibitor complexes in biological fluids. J
Exp Med. 148:223–234. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bayne K: Developing guidelines on the care
and use of animals. Ann N Y Acad Sci. 862:105–110. 1998. View Article : Google Scholar
|
|
33
|
Denman J, Hayes M, O’Day C, Edmunds T,
Bartlett C, Hirani S, Ebert KM, Gordon K and McPherson JM:
Transgenic expression of a variant of human tissue-type plasminogen
activator in goat milk: Purification and characterization of the
recombinant enzyme. Biotechnology. 9:839–843. 1991.PubMed/NCBI
|
|
34
|
Parker MH, Birck-Wilson E, Allard G,
Masiello N, Day M, Murphy KP, Paragas V, Silver S and Moody MD:
Purification and characterization of a recombinant vers ion of
human A-feto protein expressed in the milk of transgenic goats.
Protein Expr Purif. 38:177–183. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim HJ: Glycosylation variant analysis of
recombinant human tissue plasminogen activator produced in
urea-cycle-enzyme-expressing Chinese hamster ovary (CHO) cell line.
J Biosci Bioeng. 102:447–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Farid SS: Process economics of industrial
monoclonal antibody manufacture. J Chromatogr B Analyt Technol
Biomed Life Sci. 848:8–18. 2007. View Article : Google Scholar
|
|
37
|
Barrett AJ, Rawlings N and Woessner J:
E-STREAMS: Electronic Reviews of Science and Technology. Handbook
of proteolytic enzymes. 2nd edition. Elsevier; Amsterdam: pp.
2946–2952. 2004
|
|
38
|
Kwon JY, Yang YS, Cheon SH, Nam HJ, Jin GH
and Kim DI: Bioreactor engineering using disposable technology for
enhanced production of hCTLA4Ig intransgenic rice cell cultures.
Biotechnol Bioeng. 110:2412–2424. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rader RA: Expression systems for process
and product improvement. BioProcess Int. 66(Suppl 4): pp. S4–S9.
2008, http://www.bioprocessintl.com/wp-content/uploads/2014/05/BPI_A_080606SUPAR01__78704a.pdf.
|
|
40
|
Ryll T: Antibody production using
mammalian cell culture-how high can we push productivity. SIM
annual meeting program & abstract San Diego: pp. S1462008
|
|
41
|
Luo Y, Wang Y, Liu J, Lan H, Shao M, Yu Y,
Quan F and Zhang Y: Production of transgenic cattle highly
expressing human serum albumin in milk by phiC31 integrase-mediated
gene delivery. Transgenic Res. 24:875–883. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zhou Y, Lin Y, Wu X, Xiong F, Lv Y, Zheng
T, Huang P and Chen H: The high-level expression of human tissue
plasminogen activator in the milk of transgenic mice with hybrid
gene locus strategy. Mol Biotechnol. 50:137–144. 2012. View Article : Google Scholar
|
|
43
|
Fujiwara Y, Miwa M, Takahashi R,
Hirabayashi M, Suzuki T and Ueda M: Position-independent and
high-level expression of human alpha-lactalbumin in the milk of
transgenic rats carrying a 210-kb YAC DNA. Mol Reprod Dev.
47:157–163. 1997. View Article : Google Scholar : PubMed/NCBI
|
